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CHAPTER 1
INTRODUCTION
Zinc (Zn) is ubiquitous. It is an essential micronutrient in all living cells. In mammals Zn
is the second most abundant essential trace metal. This transition metal is a component of many
metalloproteins and thus functions either as a co-factor for many metallo-enzymes or as a
structural element for Zn-finger or ring-finger proteins (10, 91). Since Zn2 is a small,
hydrophilic, and a highly charged ion, it cannot be transported across the plasma or intracellular
organelle membrane by passive diffusion. In excess Zn can be toxic and its regulation is vital in
any organism. Zn is regulated with the help of chelators and a number of different Zn transporter
proteins which help uptake and distribute it around the cell (26, 35, 77). Different types of cells
require a different constant concentration of Zn at all times. Presence of excess free Zn ions can
be toxic to the cell. All cells must have tightly regulated homeostatic mechanisms in order to
preserve healthy levels and proper compartmentalization of Zn. This is accomplished through the
actions of specialized proteins that facilitate Zn uptake, efflux and compartmentalization (28,
125). If the integrity of genes responsible for maintenance of Zn homeostasis is compromised by
mutations or polymorphisms, this will likely result in complex genetic variations and even
sensitivity to dietary Zn in health and disease.
Zn plays fundamental housekeeping role in physiology, cellular metabolism and gene
expression. It is necessary for stabilization of thousands of protein domains and is required as a
catalytic cofactor of more than 300 enzymes (145, 11, 10). Recent global searches within the
human genome estimated that about 10% of the human proteome consists of potential Znbinding proteins (3). Thus, it is clear why a large number of biological processes are dependent
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on Zn homeostasis. Finally, an imbalance of Zn homeostasis has complex implications in a
human body and can ultimately contribute to the onset of chronic pathologies (157, 118).
By consumption of meat and other sources of animal proteins, humans can obtain their
Recommended Daily Allowance (RDA) of Zn, which is 12–15 mg/day. Animal proteins have
high Zn content and the metal is already bound to ligands, which facilitate its absorption.
Alternative sources of Zn include sea-foods, dairy products, cereals and even nuts (73).
Unfortunately, majority of vegetables are not ready sources of Zn because of the presence of
phytate, abundant in legumes and cereals. Phytate is known to chelate metal ions and inhibit their
absorption (78). Therefore, diets low in animal proteins but rich in phytate contribute to the high
incidence of mild–moderate Zn deficiency in developing countries (33). Although, even
individuals feeding on a balanced diet may also undergo suboptimal intake of Zn as result of
specific physiological status. This could be evident during pregnancy or acute inflammation
(Table 1.2) (33). Human brain, being a mystery that it is, still has not been fully investigated for
expression of all known members of ZIP and ZnT families.
Based on their structural and functional features human Zn transporter proteins have been
grouped into two families: Solute Carrier Family 39A (SLC39A), which includes mammalian
ZRT/IRT-related proteins (ZIPs), and Solute Carrier Family 30A (SLC30A), which comprises
mammalian ZnTs (28, 125, 28). These two transmembrane families of Zn transporters are
believed to have opposite roles in cellular Zn homeostasis. Both ZIPs and ZnTs contain a high
content of lipophilic amino acids (33). While ZnT transporters reduce the cytoplasmic Zn by
promoting export of Zn out of the cell or sequestration of Zn into subcellular compartments
during cellular Zn abundance, Zip transporters’ function is to increase the cytoplasmic Zn
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concentration by enhancing Zn uptake or release of the stored Zn from subcellular compartments
to the cytoplasm of the cell when Zn is deficient (19, 27, 47, 69, 70, 81, 82, 94, 95, 104, 121,
122, 126, 134, 136, 137, 151, 152). Thus far, fourteen members of Zip family and ten members
of the ZnT family have been identified through mouse and human genome analyses (68, 33). The
fourteen ZIP-encoding genes that have been identified in the human genome have been grouped
into four sub-families according to the molecular features of the encoded proteins. Furthermore,
amongst these Zn transporters, seven Zip proteins (Zip1-7) and eight ZnT proteins (ZnT1-8) have
been functionally characterized. Even though the role of ZIP transporters in humans, mice, and
bacteria, including their contribution to overall metal-homeostasis and their mechanism of
action, is not well understood, this defect in metal transport has been associated with numerous
diseases (130, 146, 104). For instance, mutations in two Zn transporters have been linked to the
Zn deficiency diseases acrodermatitis enteropathica (ZIP4) in humans and lethal milk syndrome
(ZnT4) in mice (146, 104).
In E.coli, the uptake of Zn is mediated by two major types of transporters: ZnuACB,
which belongs to the cluster C9 family of (TroA-like) ATP-binding cassette (ABC) transporters,
and ZupT, which is a member of the ZIP family of transporters (80, 84). ZupT is a broad
substrate spectrum metal permease whose exact mechanism of action is currently unknown, but
it has been proposed that it may involve a chemiosmotic transmembrane gradient (55).
1.1 What are ZIP transporters?
Maintaining metal homeostasis is one of the primary goals for organisms found
throughout biology. In eukaryotes this is partly achieved by ZRT/IRT-like protein (ZIP)
superfamily of metal transporters (30, 115). This superfamily has derived its name from some of
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its first identified members (ZRT, IRT-like protein) (115). It was originally believed that these
transporters only transported iron or zinc (115). They were also shown to transport cadmium and
manganese (42, 43, 90, 129). In fact, the first identified member of this family, which was Ironregulated transporter-1 (Irt1), from Arabidopsis, while selectively binding and importing iron
was also able to mediate transport of cadmium, manganese, and zinc (42, 43, 91, 129). Two other
members of this family were identified in yeast. These were Zn-regulated transporter-1 (Zrt1)
and Zrt2, which are involved in yeast’s Zn uptake (72, 71). Altogether, around 85 ZIP family
members have been identified from bacteria, archaea and different eukaryotes, plus 15 genes in
Arabidopsis (113). Amino acid sequences alignment groups ZIPs into four sub-families, even
though all of the higher plant genes seem to fall into a single group (113).
1.2 ZIPs vs. ZnTs
In order to maintain a healthy homeostasis of such essential metals like Zn, mammals
have been equipped with the Zn transporter (ZnT) family of proteins. ZnT family of proteins is
believed to have an opposite role on Zn homeostasis when compared to the ZIP family. While all
of the ZIP proteins mediate Zn uptake from the extracellular environment or intracellular
vesicles into the cytoplasm, proteins belonging to the ZnT family are accountable for Zn efflux
from the cytoplasm towards either intracellular vesicles or/and the extracellular space, as well as
for Zn delivery to precise metalloproteins (81, 76). ZnT family of proteins is unique in a way that
its members function in a tissue-, cell-, and organelle-specific manner in order to maintain the
levels of Zn in check (94). Due to the importance of these metal transporters, it is no wonder that
there have been ten of the members of Znt family indentified in mammals. Unlike ZIP family
proteins, which have eight transmembrane domains, these encompass six predicted
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transmembrane domains and thus are believed to function as multimers. Finally, Zn is the key
regulator to the gene expression of Znt1, while dietary Zn controls the mRNA levels of Znt1 and
Znt2 in liver, intestines, and kidneys (97, 108).
1.3 Importance of ZIP family in plants
For healthy growth and development plants require transition metals like Zn, Fe, Cu, and
Mn. These are acquired from the soil and distributed around the plant depending on their needed
concentrations within the different cells and organelles. In excess, the same metals can be toxic
to the cell if proper regulatory mechanisms are not in place to regulate their concentrations (5).
The membrane transport systems responsible for regulation of metal concentrations in plants
include the ZIP family, the heavy metal (or CPx-type) ATPases (HMAs), the natural resistanceassociated macrophage proteins (Nramps), the cation diffusion facilitator (CDF) family, and the
cation antiporters (115, 155, 51). In the last decade our knowledge of these transporter families
has increased drastically. A summary of ZIP family members contributing to plants’ metal
homeostasis, their metal specificity and tissue localization is outlined in Table 1.1. Their
proposed membrane localization on the other hand can be found in Figure 1.1. Overall, possible
transporters of all essential metals, besides Mo, have been proposed thus far (79).
Not surprisingly, as seen in Table 1.1, ZIPs are for the most part expressed within the
roots of the plants and their metal specificity encompasses such metals like Zn, Fe, Cd, and Mn.
Two of them, LeIRT1 and LeIRT2, are proposed to have a broad range of metal specificity. Even
though IRT1 preferentially transports Fe, it has also been shown to transport Mn, Cd, and Zn (42,
43, 90, 129). Interestingly, most essential metals have at least two gene families with specificity
for its transport. For instance, Fe can be transported by ZIPs and Nramps, while Zn is a substrate
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for ZIPs and CDFs. Furthermore, when compared to yeast that only has 3 ZIP genes, Arabidopsis
has a shocking 15 ZIP genes. Some of these transporters are possibly involved in active efflux
while others in influx (153). This also contributes to the differences apparent in their affinities
for different metals. Whereas majority of ZIP proteins transport Zn, another reason for existence
of multiple zip genes in any given organism could be that they may differ in the metals that they
transport in the biological context of a given organism (94). To cope with varying metal
availabilities both high and low affinity mechanisms are needed, which is the case in yeast (34,
147). As seen in Figure 1.1, it takes a large number of different genes, including ZIPs, to
facilitate both uptake and efflux mechanisms in plants in order to provide responses to a variety
of environmental stress conditions.
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Table 1.1 Proposed specificity and location of ZIP family metal transporters in plants (79)

Name

Family members in
A. thaliana
Proposed specificity Cellular location

ZIP

15
PM

Main tissue expression

IRT1

Fe, Zn, Mn, Cd

Roots

IRT2

Fe, Zn

Roots

OsIRT1

Fe

Roots

LeIRT1

Fe (broad?)

Roots

LeIRT2

broad?

Roots

TcZNT1

Zn, Cd

Roots, shoots

TcZNT2

–

Roots

ZIPs1‐3

Zn

Roots

ZIP4

Zn

Plastids

Roots, shoots

GmZIP1

Zn

Peribacteroid membrane

Root nodules
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Figure 1.1
Summary of proposed transition metal transporters identified in plants thus far
Membrane localization of some of these transporters, especially those at the plasma
membrane is yet to be confirmed (79).
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Plants require Fe for their normal growth and development. Unfortunately, Fe is often
difficult to obtain from the soil due to its low solubility. Therefore, plants have evolved two
mechanisms to conquer this problem (65, 138). Strategy II is utilized by grasses, which secrete
phytosiderophores that chelate Fe3+ after which the complex is absorbed through the roots.
Though, majority of plants depend on Strategy I that involves using reductive mechanism in
order to mobilize Fe3+. By acidifying the soil, plants reduce ferric ions through a plasma
membrane-located Fe3+ chelate reductase. Roots then absorb the ferrous ions with the help of a
Fe2+ transporter.
As mentioned earlier, AtIRT1, the first member of the ZIP family to be identified, was
cloned from Arabidopsis via functional complementation of an iron-uptake-deficient yeast
mutant (fet3 fet4) (42, 79). In roots, IRT1 is believed to be the main transporter for high affinity
Fe uptake (21, 150). At Fe-deficient conditions, after 24 hours IRT1 mRNA is detectable (21). In
addition, IRT1 mRNA and protein levels peak after 72 hours, while its mRNA and protein
remain undetectable 12 hours after shifting back to Fe-adequate conditions (21). Interestingly,
under Fe-scarce conditions, plants overexpressing AtIRT1 are also found to accumulate elevated
concentrations of Cd and Zn than their wild type counterparts (21). This discovery was also
supported by transport studies done in yeast (42, 90). Also, as seen in the T. caerulescens
ecotype Ganges, the uptake of Cd but not Zn was drastically improved by Fe deficiency, and this
might have resulted due to an increase of TcIRT1-G mRNA in root tissues (110).
A knockout of IRT1, created in Arabidopsis, showed severe growth defects and was
chlorotic, although application of exogenous Fe was able to rescue the condition (150). The
protein was found to localize to the plasma membrane, and during Fe-deficient conditions it was
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mainly expressed in the root’s external layers. In addition, IRT1 mutants showed major changes
in their photosynthetic efficiency and developmental defects were noted which were believed to
be consistent with Fe transport/deficiency (62, 148). Surprisingly, during Fe deficiency AtIRT2
is also expressed in root epidermal cells (12). Yet, it was unable to substitute the loss of IRT1
(120). It also seems to have a higher specificity for its substrates: while it was reported to
complement Fe and Zn uptake mutants it was unable to transport Cd or Mn in yeast (149).
Overall, these two transporters might have different functions in Arabidopsis.
These ZIP family transporters have also been identified and studied in tomatoes. Here,
for the most part, they are expressed in roots (40). Also as seen before, LeIRT1, but not LeIRT2,
was robustly enhanced by Fe deficiency and it was up-regulated by P and K deficiencies in the
root medium (153). In rice, OsIRT1, with a high homology to the AtIRT1 gene of Arabidopsis,
just like in tomatoes was also highly expressed in roots and was induced by Fe-deficiency and
additionally by Cu-deficiency (12). These results have an implication of a possible co-regulatory
mechanism for some essential minerals’ transporter genes.
Yeast complementation studies have contributed greatly to our understanding of the
functional properties of plant ZIP transporters. It was reported that ZIP transporters 1–3 from
Arabidopsis are able to restore Zn uptake to yeast Zn uptake mutants zrt1 zrt2; and thus were
projected to influence transport of Zn (58, 115). In Zn-deficient plants, ZIPs 1, 3 and 4 were
expressed in the roots, while ZIP4 was additionally found in the shoots and is expected to have a
chloroplast-targeting sequence (58, 115). In yeast, ZRT1 was reported to be a high affinity Zn
transporter, which is glycosylated and expressed at the plasma membrane (34). ZRT2, on the
other hand, was reported to be a low affinity Zn transporter (115). Furthermore, another ZIP
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homologue found in yeast, ZRT3 was reported to be involved in the mobilization of stored Zn
from the vacuole (112). Similarly, TcZNT1, from the Zn/Cd-hyperaccumulating plant, Thlaspi
caerulescens was shown to facilitate high-affinity Zn uptake and low-affinity Cd uptake after
expression in yeast (123). High levels of TcZNT1 were expressed in root and shoot of T.
caerulescens, meanwhile overexpression of this transporter due to a change in Zn concentration
resulted in amplified Zn influx in the roots (6). Finally, it was reported that TcZNT1 and TcZNT2
were mostly expressed in roots, but their expression was not associated with Zn availability (6).
Unlike in T. caerulescens, in the non-hyperaccumulator T. arvense, TcZNT1 and TcZNT2 were
shown to be exclusively expressed during Zn deficiency (6).
One of the members of the ZIP family, GmZIP1, has now been identified in soybean
(117). According to functional complementation studies, of the zrt1 zrt2 yeast cells, GmZIP1 is
greatly selective for Zn (117). It was also reported that yeast Zn uptake was inhibited by Cd
(118). Unlike the previously mentioned ZIP genes, GmZIP1 was specifically expressed in the
nodules and not in roots, stems or leaves (117). Moreover, its protein was localized to the
peribacteroid membrane, which implicates a possible role in the symbiosis (117).
Overall, the proposed role of ZIP transporters in Zn nutrition is well supported by the
characterization of homologues from different species (37). Studying the above discussed metal
transporter families in plants is crucial to humans. The knowledge elucidated can be useful in
genetic modification of certain species, either to improve the metal quality of crops for human
and animal nutrition or for the purposes of phytoremediation, which is a technology that uses
plants to remove toxic elements from soil.
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1.4 Roles of ZIPs in bacterial infections
Integrity of the bacterial cell envelope is crucial for a large number of fundamental
physiological processes. These include nutrient uptake, cell wall synthesis, signal transduction,
motility, energy generation, protein folding and secretion. It has been shown that all of the ZIP
proteins mediate Zn uptake from the extracellular environment or intracellular vesicles into the
cytoplasm (28). It has also been shown that in mammals Zn has an important immunomodulatory
function and is absolutely critical for innate and acquired immunity (111). Furthermore, after
exposure to lipopolysaccharide (LPS) Zn levels decrease in the serum and Zn accumulates in the
liver (109). Even though Zn concentrations are estimated to be in the millimolar concentrations
within host cells, available Zn might be unattainable to bacterial pathogens and/or significantly
reduced after activation of innate immune defenses (2, 111). Unfortunately, Znu, the highaffinity Zn uptake system tends to mask the action of ZupT (132, 130). According to the recent
studies, a role in pathogen fitness for ZupT, along with ZnuABC, during urinary tract infection
was found in mice (130).
In order to protect themselves from intracellular pathogens, infected vertebrates perform
sequestration of extracellular Zn, but they also decrease their cellular Zn concentrations (22,
111). The bacteria are engulfed into phagosomes, by phagocytic and antigen presenting cells of
the immune system, which unite with lysosomes that contain antimicrobial factors. Macrophages
and IFN-γ stimulated T cells are known to express ZIP8 (8, 7). When T cells are stimulated,
ZIP8 associates with the lysosomal protein Lamp1, which suggests a possible association with
the lysosome (7). Additionally, it was shown that in transfected human embryonic kidney cells
ZIP8 is also found associated with lysosomes (8). Since ZIP8 is a member of ZRT/IRT family it
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was no surprise that the initial studies showed that it is possibly capable of transporting Zn (8).
Furthermore, it has been determined that T cells decrease lysosomal Zn levels upon activation of
cells overexpressing ZIP8, while there is an increase of cytosolic Zn levels (8, 7). The above
suggests that ZIP8 is positioned to transport Zn from the lysosome into the cytoplasm, which in
turn disrupts zinc-dependent bacterial processes.
Decreasing lysosomal Zn levels is not sufficient, thus vertebrates also reduce their
cytoplasmic Zn levels in order to combat a bacterial infection. When dendritic cells are
stimulated with lipopolysacharide, a decreased expression of ZIP importers is observed along
with subsequently an increased expression of ZnT Zn exporters (116, 87). As a result, cytosolic
Zn levels are decreased (111, 116, 87). It is unknown if this alteration of Zn concentration affects
the invasive pathogens. It has been shown that alteration of Zn levels has an impact on dendritic
cell maturation and activation, as well as on T-cell development (156, 7, 116, 87). This makes it
rather impossible to determine the role of modified Zn concentrations on virulence and microbial
growth.
It is for certain that a decreased level of Zn can lead to a disruption of a large number of
bacterial processes which would impact the pathogen’s ability to infect the host. Bacteria
incorporate Zn into approximately 4–6% of all proteins (4). This essential metal is exploited in
control of bacterial gene expression, for cellular metabolism, and as a cofactor of bacterial
virulence factors. For instance, the iron responsive regulator Fur, alcohol dehydrogenases, lyases,
hydrolases, and Cu/Zn superoxide dismutases are all bacterial proteins that utilize Zn (88, 11). In
order to overcome Zn sequestration, bacteria express high affinity Zn transporters. At the
minimum there are two kinds of Zn uptake systems that are used by bacteria. Most common one
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is homologous to the high affinity ZnuABC transport systems, which are found in E. coli (84). In
general, these Znu-like systems have been associated in a number of Gram-negative and Grampositive bacteria (84). Additional system of Zn transporters resembles the eukaryotic ZIP family
transporters, even though its homologs have only been found in E. coli (84).
Worthy of mention is that bacterial Zn and Mn transporters are both a part of the cluster 9
family of ABC transporters (84). This similarity complicated the identification of a transported
substrate. Examples of this include the metal binding protein PsaA from Streptococcus
pneumonia that has been shown to transport Mn in vivo although it contains Zn-coordinating
histidine and aspartic acid residues, which are highly conserved between Zn transporters (84,
98). Additional example is TroA, a component of the Treponema pallidum TroABC transport
system, which is homologous to the Mn binding protein MntA from Bacillus subtilis and
therefore was expected to transport Mn. Unfortunately, crystallographic studies along with
heterologous expression in E. coli propose that TroA is a Zn transporter instead (84, 101, 59). It
is sometimes difficult to predict a correct substrate for a given transporter, thus only careful
biochemical studies could show the true colors for all of these metal transporters.
On the other hand, inactivation of ZnuABC transport systems in quite a few bacterial
pathogens, including Campylobacter jejuini, Salmonella enterica, Haemophilus ducreyi,
Uropathothogenic E. coli, Brucella abortus, and Streptococcus pyogenes results in decreased
virulence/colonization of bacteria (29, 2, 103, 130, 13, 154, 86). Other mechanisms for
overcoming Zn sequestration could exist. At the end, more studies need to be conducted in order
to characterize Zn acquisition systems in bacteria as well as to understand the role of Zn
sequestration of the host and its impact on bacteria.
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In addition to sequestering Zn, as a defense mechanism against bacterial invaders,
vertebrates also sequester Fe and Mn (41, 144, 22). Figure 1.2 below depicts the proposed
current model for the battle between invertebrates and bacterial pathogens for non-iron nutrient
metals. New discoveries show a possibility that nutritional immunity might include other
essential transition metals like copper or nickel. Along with high affinity transport systems,
bacterial pathogens might express siderophore-like molecules to mediate the acquisition of noniron transition metals. This was observed in methanotrophs in which methanobactin assists
copper acquisition through mechanisms similar to siderophore-mediated iron capture (124). Just
like with Zn sequestration, further investigation is needed to entirely understand the battle for
transition metals between the host and bacteria. Furthermore, studying acquisition of non-iron
transition metals could provide useful information about the bacterial physiology which in turn
could be useful in development of new therapeutics.
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Figure 1.2
The battle for transition metals between the host and bacteria
(a) Keratinocytes express the antimicrobial compounds S100A7 and S100A15 that in turn
sequester metals and prevent infection. After microbial infection, (b) the neutrophil proteins
S100A8/S100A9 (calprotectin) and S100A12 bind Mn/Zn and Cu/Zn, respectively. (c)
Activated dendritic cells alter the expression of ZIP importers and ZnT exporters, which
results in reduced cytoplasmic levels of Zn. Expression of ZIP8 by macrophages, dendritic
cells, and T cells results in decline of lysosomal Zn concentrations. Nramp1, widely expressed
by phagocytic cells, transports Mn out of the lysosome. (d) In order to compete with hostmediated Zn and Mn sequestration bacteria express high affinity metal transporters (140).
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1.5 Expression of ZIPs and ZnTs in human body with respect to Zn imbalance
1.5.1 Asthma linked to Zn deficiency
Asthma is a clear example of the importance of Zn homeostasis. This disease is
characterized as a chronic airways inflammatory disease, which results from environmental
factors in already genetically predisposed individuals (36). Hallmarks of asthma include
recurring incidents of wheezing, breathlessness and chest tightness triggered by airway
inflammation. Furthermore, an increasing number of studies have been linking asthma to Zn
deficiency (31, 135).
Expression of ZIPs and ZnTs in disease pathology of asthma due to Zn imbalance is
summarized in Table 1.2 below. According to one of the studies, individuals with low Zn
consumption displayed a four- to five-fold higher combined risk of bronchial reactivity, atopy,
and allergic-type symptoms than individuals with higher Zn consumption (31, 135).
Additionally, in a 5-year follow up study, it was shown that Zn intake during pregnancy is
negatively associated with asthma and shortness of breath in children later on in life (32). In a
different study, Zn levels were measured in the hair of wheezy infants as well in healthy controls
to show that Zn levels were significantly lower in infants suffering from wheezing (118). This
sparked a theory that Zn levels, its deficiency, might contribute to the wheezing during early
childhood (50).
Stainings of airway epithelium from different species had one thing in common: an
intense Zinquin staining. Zinquin is a Zn-specific fluorescent probe, and its staining here was
completely quenched in the presence of the Zn chelator TPEN (N,N,N',N'-tetrakis-(2pyridylmethyl)-ethylenediamine) (142). Labile Zn is a more dynamic, free or loosely bound form
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of Zn that is more readily exchangeable. Here, labile Zn pools were for the most part found
associated with apical structures, which were in the proximity of cilia basal bodies (143, 15).
Furthermore, it has been shown that a deficit of Zn results in airway epithelial cells becoming
highly susceptible to apoptosis, which is induced by oxidants or by the FAS death receptor
pathway (15). It was proposed that programmed cell death may be responsible for acute lung
injury due in part to epithelial cell loss. Exhaustion of labile Zn along with tumor necrosis factor
alpha (TNF), interferon gamma (IFN) and FAS receptor stimulation quickens caspase-3
activation, proteolysis of E-cadherin and β-catenin, as well as cellular apoptosis. This results in
amplified paracellular leak through monolayers of both upper airway and alveolar lung epithelial
cultures. Surprisingly, supplementation with Zn successfully inhibited both apoptosis and
paracellular leak (131).
Animal models can be utilized to mimic human asthma condition. This is achieved by
facilitating allergic airway inflammation using Balb/c mice. Following sensitizing, these mice
are aerochallenged with ovalbumin (OVA) which leads to development of airway eosinophilia
that is correlated with airway hyper-responsiveness, damage of airway epithelium, mucous
hyperplasia and collagen deposition (45). The resulting airway inflammation leads to depletion
of stainable Zn. Furthermore, when mice are fed varying diets, those with Zn limited diets (ZL,
14 mg/kg Zn) after exposure to the allergen OVA displayed higher airways hyperresponsiveness, along with elevated mucus cell hyperplasia and eosinophilia, when compared to
mice fed a Zn sufficient diet (ZN, 50 mg/kg Zn) (143). After attaining airway inflammation in
mice null for the MT-I and MT-II gene functions, the animals demonstrated significantly
elevated eosinophils and neutrophils in broncheo-alveolar fluid when compared to wild type
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controls. Additionally, there were increased expressions of interleukin1β, 8-oxy-deoxyguanoside
and nitrotyrosine (74). All of the above findings indicate that Zn and MT provide a protective
role against antigen-induced airway inflammation (160). Finally, supplementation with Zn
decreases infiltration of inflammatory cells after acute airways inflammation, here induced by
OVA (161).

Table 1.2 Expression of ZIPs and ZnTs in disease pathologies due to Zn imbalance (33)
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In mice supplemented with Zn, enhanced expressions of ZIP1 and ZIP14 were observed, while a
decline was evident in ZIP4 and ZnT4 expressions. The observed alterations in gene expressions
of these Zn transporters, during airways inflammation, resulted as an attempt to achieve
intracellular Zn homeostasis (96). Overall, this study showed that proteins that are responsible
for regulating Zn fluxes are crucial in maintaining airways physiology and are important during
the onset of inflammatory diseases.
1.5.2 The role of Zn deficiency in Diabetes
Disturbed glucose homeostasis and varying degrees of hyperglycemia are hallmarks of
diabetes. Pancreas has a very intricate architecture, which is for the most part composed of
exocrine acinar cells that synthesize and secrete the components of pancreatic juice. Also, the
islets of Langerhans, which are scattered within the exocrine tissue, comprise the endocrine
component of the pancreas (33). Zn, on the other hand, is found throughout the pancreas (33).
Expression of ZIPs and ZnTs in disease pathology of diabetes due to Zn imbalance was
summarized in Table 1.2 earlier.
This essential metal is a vital part of pancreatic juice (33). Additionally, Zn is found to be
more concentrated in endocrine islet cells, and even more so in the secretory vesicles of β-cells
where it is known to stabilize the structure of insulin granules (Figure 1.3) (17, 92). Using
Zinquin, coupled with digital image analysis, it was possible to visualize labile Zn, as well as
measure it in intact islets and dissociated islet cells (33). Labile Zn was found to be concentrated
in secretory vesicles (33). A scattered cytoplasmic fluorescence signal was due to an
extragranular pool of labile Zn, which in turn could be used by the newly formed secretory
granules (159).
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Figure 1.3
Zinquin staining of a section of mouse pancreas (A), mouse glucagonoma α-TC1 cells (B) and
mouse insulinoma β-TC6 cells (C). Arrows indicate two islets of Langherans surrounded by
acinar exocrine cells (33).

External stimuli like an increase in glucose concentration results in a change of
intracellular free Zn concentration. Interestingly, it was shown in vitro that presence of 25.6mM
glucose diminishes Zinquin staining (159). Presence of Zn ions in beta cells facilitates more than
stabilization of insulin hexamers: it has been postulated that released Zn ions might provide a
paracrine effect in promoting glucagon secretion, mediated by alpha cells (75). In contradiction,
a different study reported Zn to have an inhibitory effect on glucagon secretion in isolated
pancreata and dissociated alpha cells (46). Finally, it was also shown that Zn ions released by
beta cells might add to their own destruction during insulin hypersecretion (85).
It has been predicted that Zn homeostasis might be significant in the onset and/or
progression of diabetes. This claim has been strengthened by results from studies conducted in
man and rodent models (1, 17). In mice, it was shown that supplementation with dietary Zn
protected the rodents against chemically induced diabetes (66). Meanwhile, in human patients, a
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lower serum Zn concentration was observed in Type 1 diabetes when compared with healthy
controls (139). In summary, Zn deficiency might be responsible for the decreased ability of the
pancreas to respond to glucose, which ultimately leads to islet cell damage (1). Tyrosine
phosphatase 1B, an enzyme which is a key regulator of the phosphorylation state of the insulin
receptor is targeted by Zn ions that are known to display insulinomimetic effects. In addition,
according to the recent studies local Zn deficiencies might play an important role in the
development of insulin resistance by activation of stress pathways, with a loss of tyrosine
phosphatase control as an end result (64, 63).
Recently, the mouse pancreas was used to investigate the correlation between dietary Zn
and the expression of Zn transporters (33). As a result, 16 ZIP and ZnT transporters were
revealed to be expressed (33). Also, a human genetic study identified a SNP in the promoter
region of the MT2A gene that is closely associated with Type 2 diabetes (52). Unfortunately,
there is no information available on the incidence of SNPs in Zn transporter genes, as well as on
their possible involvement in the development of pancreas-related pathologies. Disruption of Zn
homeostasis can result from improper dietary intake of Zn, but also from impaired activity of
proteins controlling Zn metabolism (Figure 1.4) (33).
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Figure 1.4
The outcome of the interaction between diet and allelic variations of genes controlling Zn fluxes
on the balance between health and disease (33)
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1.5.3 Link between Zn & Alzheimer's disease
Alzheimer's disease (AD) is a polygenic neurodegenerative disorder linked to aging. Its
hallmarks include progressive impairment of memory and cognitive abilities. The onset of AD is
believed to be due to the abnormal accumulation and deposition of extracellular senile plaques,
which are made up of Cu-Zn aggregates of the amyloid β-peptide (Aβ). In turn, Aβ results from
proteolytic cleavage of the precursor APP (amyloid β-protein precursor), which is a member of
an integral membrane glycoprotein family. There is a cysteine-rich specific domain which is
conserved in all APP superfamily members (67). Zn ions are known to bind this domain (33).
Numerous studies are pointing to Zn’s involvement in AD pathogenesis, as well as its
distorted metabolism in AD’s pathology (67). Expression of ZIPs and ZnTs in disease pathology
of Alzheimer’s due to Zn imbalance was summarized in Table 1.2 earlier. Excess Zn, in
particular, was found associated with amyloid plaques (67). Also, the interaction of Aβ with Zn
and other biometals was found to promote amyloid plaque aggregation and decrease its solubility
in vitro (67). Since proper AD diagnosis can only be done post-mortem, one of the greatest tools
to study AD is to use the transgenic mouse model Tg2576. These transgenic mice overexpress an
isoform of human APP, which contains the K670N, and the M671L mutations (157, 141). At 3
months these animals have normal learning and memory in spatial reference, but by 10 months
both parameters are impaired (67). This is characteristic of Aβ plaque deposition (67). When
these animals were treated with clioquinol, an orally bioavailable metal chelator, a significant
inhibition of cortical amyloid accumulation was observed (18). Besides, even early-phase
clinical trials suggested that Aβ plaque deposition can be inhibited by Zn chelation (128, 49).
Due to high Zn concentrations in the brain, its transport and regulation here are crucial.
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Zn is mainly accumulated in the glutamate synaptic vesicles of presynaptic nerve terminals.
Furthermore, Zn ions inhibit postsynaptic glutamate receptors. Excitation with glutamate leads to
a quick uptake of Zn via a saturable transport system. Following Zn uptake, Zn along with
glutamate is resealed during neurotransmission and has been reported to reach concentrations as
high as 300 μM in the synapse (49). Excess Zn must be removed in order to protect adjacent
neurons: excess of extracellular Zn is toxic and could contribute to brain damage, as seen in
transient cerebral ischemia (141, 89).
On the contrary, Zn deficiency can also have devastating consequences in human
physiology. It has been shown to drastically affect behavior of infants and children. Fortunately,
there is a very tight regulation of Zn homeostasis in our brain, since brain Zn concentration is
found to remain within a narrow range. Moreover, one study in mice, fed with a Zn-limiting diet,
showed a decline in the expression of MT-I and ZnT1, meanwhile a Zn importer ZIP6 was found
to be upregulated (20). This finding could suggest a possible mechanism that brain employs in
order to preserve Zn during Zn deficiency (20).
Overall, Zn homeostasis in the brain is maintained by the actions of metallothioneins,
ZnTs and ZIP proteins. Similarly to other cell types, in neurons Zn is mainly found tightly bound
to metallo-proteins. In the brain, just as seen earlier during bacterial infections, Zn is sequestered
but into synaptic vesicles of glutamatergic neurons (122). In order to transport high
concentrations of labile Zn, from the cell bodies to the axon terminals where it’s packaged into
synaptic vesicles, this cell type utilizes the ZnT3 transporter (122). Interestingly, when a ZnT3(/-) genotype was introduced into Tg2576 mice brain development and learning abilities were not
affected, instead it resulted in an approximately 50% reduction in amyloid burden (99). It was
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found that ZnT3 expression was regulated by estrogen. This was no surprise, since both in
humans and rodents there is a higher occurrence of AD in postmenopausal females when
compared to males of equal age. Additionally, in comparison with males, in aging
Tg2576:ZnT3(+/+) female mice there were increased levels of synaptic Zn, insoluble amyloid
beta, along with plaques (99, 100). The above physiological attributes, which were clearly sexlinked, were not present in Tg2576:ZnT3(-/-) (99, 100). While more studies are necessary to
elucidate the true roles of metal transporters in the brain, their importance in the onset and
progression of neurodegenerative diseases, like AD, is undeniable.
In a nutshell, many factors contribute to the onset and progression of multifactorial
diseases. As described above, these include genetic and environmental factors, such as diet.
Using mutation screens along with linkage studies, scientists have been able to identify a number
of mutations in several genes attributing to chronic diseases. Furthermore, numerous reports are
singling out Zn, as well as its metabolism, as the key player in the onset of a rising number of
chronic diseases. Therefore, research of Zn’s metabolism and regulation, by metal transporters
like those belonging to the ZIP family, will illuminate the influence of dietary Zn on disease risk.
1.6 ZIP’s structures & their metal-binding implications
Searches of human and mouse genomes revealed numerous members of ZIP superfamily,
including as many as 14 in humans. Additionally, there was a conserved subfamily that was
identified in mice and humans. It includes three zip genes: zip1, zip2, and zip3. Furthermore,
human ZIP1 (SLC39A1) along with ZIP2 (SLC39A2) have been shown to act as Zn transporters
(94, 95). In these studies, Zn transport was measured in mammalian cells which were transiently
transfected with an empty vector or a vector containing hZip1 or hZip2 cDNAs (94, 95). To
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determine the role of these genes in Zn transport transfected K562 erythroleukemia cells
expressing these genes were utilized (94, 95). Cells expressing hZip1 were shown to accumulate
more Zn than control cells because of increased Zn influx (95). These cells also showed a Znuptake profile that was biochemically indistinguishable from the endogenous activity (95). On
the other hand, it was observed in cells expressing hZip2 that Zn transport was time-,
temperature-, and concentration-dependent and saturable with an apparent K

m

of 3 μM (94).

While hZip1’s activity was not energy-dependent, nor did it require K+ or Na+ gradients, it was
stimulated by HCO3- treatment, suggesting a Zn-HCO3-cotransport mechanism (94). Finally,
both hZip1 and hZip2 were observed to localize in the plasma membrane (94, 95). Furthermore,
a mutation in the human ZIP4 gene (SLC39A4) was found in the genetic Zn metabolism disorder
acrodermatitis enteropathica (152). Also, that it is responsible for encoding a Zn-regulated Zn
transporter in mice. Since it is a conserved gene, it further underlines the fact that mammalian
ZIP genes are vital components of the Zn homeostasis mechanism (38).
Thus far there hasn’t been a study conducted in vivo in order to assess the three zip gene
systemic expression and regulations. While ZIP1 mRNA has been reported to be present in most
human tissues as well as in cultured human cell lines, zip1 mRNA was present in majority of
adult rat and embryonic mouse tissues (95, 105). Unlike ZIP1, ZIP2 mRNA was not detected in
human tissue RNAs (94). ZIP3’s expression is yet to be determined in any system, and zip1 and
zip2 are still in need of characterization in adult mouse tissues. It was reported that in cultured
prostate cell lines there is a mild hormonal regulation of ZIP1 mRNA (23). Also, in THP-1 cells
treated with a Zn chelator, and in human monocytes, ZIP2 mRNA abundance was significantly
elevated, while ZIP1, ZIP3, and ZIP4 mRNA abundance remained the same (25, 14).
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1.6.1 Biochemical Characteristics of the ZIP family
Several of the ZIP proteins have been functionally characterized and as a result are
believed to have similar membrane topologies. This includes eight transmembrane domains, as
well as the amino- and carboxy-terminal ends found on the outside of the plasma membrane
(Figure 1.5) (28).

Figure 1.5
Topological model of SLC39 proteins
8 transmembrane (TM) domains are indicated in red. The histidine-rich region in the cytoplasmic
loop between TM III and IV, conserved histidines and charged/polar residues in TM IV and V,
and the location of substrate specificity determinants mapped in Irt1 are also shown above (28).
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These domains contain conserved histidine, serine, and glycine residues within the fourth
transmembrane domain (37). ZIP proteins are known to have a variable region, which is likely to
contain a possible metal-binding domain that is rich in His residues (56, 28). Arabidopsis ZIP
proteins, for instance, have a varying amino acid range, from 326 to 425 (115). This is all due to
the variable region that is speculated to be found in cytoplasm between transmembranes III and
IV (115). Furthermore, motifs that are found to be conserved in ZIP proteins are believed to be
involved in metal transport or its regulation. One example of this would include a motif like
HAGHVHIHTHASHGHTH that is a part of ZIP1, and is also conserved in a number of ZIP
proteins (115). These proteins also contain a histidine-rich loop, which is found between third
and fourth transmembrane domains (37, 28). Finally, there was a predicted amino acid
conservancy of 83-93% found between all 8 transmembrane domains of the mouse and human
ZIP1, ZIP2, and ZIP3 genes (Figure 1.6A, B, C) (37).
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Figure 1.6A
Sequence alignment of the mouse and human ZIP1 transmembrane domains 1-8 (37)
In these figures the shaded regions depict conserved sequences, and the 8 putative
transmembrane domains (TM) are highlighted with a solid line above the mouse sequences. The
conserved 12-amino acid signature sequence that is characteristic of this subfamily is boxed for
each ZIP.
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Figure 1.6B
Sequence alignment of the mouse and human ZIP2 transmembrane domains 1-8 (37)

32

Figure 1.6C
Sequence alignment of the mouse and human ZIP3 transmembrane domains 1-8 (37)

12-amino acid sequences, with a conserved motif: HSVFEGLAVGLQ from the human
ZIP1, ZIP2, and ZIP3 proteins, were used to search the mouse translated high throughput
genome sequences data base on the NCBI Protein Database server (37). The result yielded three
different BAC entries that were derived from the C57/B6 strain of mice. The alignment of these,
depicted in Figure 1.7 below, provided the identity of the mouse zip1, zip2, and zip3 genes (37).
Here, the fourth transmembrane domain was aligned with a few known ZIP proteins from
Arabidopses, yeast, and human. Conservation within the human sequences revealed the three
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mouse ZIP proteins belonging to a subfamily. As seen with other members of the ZIP family,
these sequences contain the conserved histidine, serine, and glycine residues (boldface). In
addition, human and mouse ZIP1, ZIP2, and ZIP3 are a part of a smaller subfamily that shares an
extended 12-amino acid sequence (underlined). The only exception is the one conserved amino
acid substitution that is seen in ZIP3 (37).

Arabidopsis

IRT1
ZIP1
ZIP2
ZIP3

ELGI I VHSVVIGLSLGATSDT
EI GI VVHSV I IGI SLGASQSI
I FAL CFHS IFEGIAI GLSDTK
ELGI I VHSVVIGISLGASQSP

Yeast

ZRT1
ZRT2

EFGVI FHSVMI GLNLGSVGD
EFG I I FHSVFVGLSLSVAGE

Human

ZIP1
ZIP2
ZIP3

VFSLALHSVFEGLAVGLQRDR
LLSL SFHSVFEGLAVGLQPTV
AFALSAHSVFEGLALGLQEEG

Mouse

ZIP1
ZIP2
ZIP3

VFSLALHSVFEGLAVGLQRDR
LL SLSFHSVFEGLAVGLQATV
VFALSAHSVFEGLALGLQEEG

Figure 1.7
Conservation within the fourth transmembrane domain revealed a subfamily of mammalian
ZIP proteins (37)

34

Earlier mentioned, SLC39 gene family has 14 greatly conserved members in the human
and mouse genomes (53). As depicted in Figure 1.8, when compared to the other 12 family
members, evolutionarily mouse ZIP14’s closest neighbor is ZIP8 (61). Noteworthy, the human
and mouse SLC39A14 genes both contain two exons 4, which give rise to ZIP14A and ZIP14B
alternatively-spliced variants. It is believed, that ~425 million years ago ZIP8 and ZIP14
diverged from one another sometime following the land animal–sea animal split (53). This
theory is based on the fact that the puffer fish, Takefugu rubripes, genome includes one gene that
is practically identical to both mouse genes (53). Not depicted here, the human SLC39A14 and
SLC39A8 genes are homologous to the mouse orthologs.

Figure 1.8
Phylogenetic tree of the 14 mouse ZIP domains of the Slc39 gene-encoded proteins (nearestneighbor joining (NNJ)-generated) (61)
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Residues in or near transmembrane helices (TMH) IV and V are critical for efficient
metal-uptake (129). Transmembrane domain IV is believed to contain the most conserved region
of these proteins. It is also predicted to form an amphipathic helix, which contains a fully
conserved histidine that may form part of an intramembranous metal binding site involved in
transport (115, 113). Furthermore, it has been shown that the transport function after
heterologous expression in yeast was eliminated after conserved histidines or some of the
adjacent residues were mutated (129). A related study was done with human hZIP1 (SLC39A1),
which indicated that histidines located within TMH and in connecting loop domains were
essential for Zn transport (114). Although there have been a number of proposed mechanisms,
the mechanism for ZIP-mediated metal ion transport is still unknown. One of them includes a
bicarbonate stimulated hZIP2 and a Zn (II)/bicarbonate co-transport (94). Bicarbonate might also
drive the metal-uptake in other ZIP-transporters, like ZIP8 (Slc39A8) and ZIP14 (Slc39A14) (60,
53).
While studying rvZIP14A and rvZIP14B cell lines, the Nebert lab revealed that ZIP14
transporters uptake Cd by a temperature- and energy-dependent method, while functioning
optimally at pH = 7.2 (61). ZIP14 proteins, in particular the B isoform, displayed a high affinity
for Cd. Furthermore, it was observed that ZIP14-mediated Cd uptake is most inhibited by Zn2+,
followed by Mn2+ and finally Cu2+. ZIP8- and ZIP14-mediated Cd uptake is dependent on
presence of extracellular HCO3-, characterizing ZIP14A and ZIP14B as M2+/HCO3- symporters,
where M2+ = Zn, Mn or Cd. Finally, ZIP14A and ZIP14B were found to be located on the apical
surface of MDCK cells (53). In Table 1.3 below, one can find a comparison between the human
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versus mouse SLC39A8 and SLC39A14 genes and in Table 1.4 the properties of the mouse ZIP8
and ZIP14 protein transporters (61).
It has been observed that Cd in the environment is capable of displacing either
endogenous Zn or Mn and then entering the epithelial cell. By forming disulfide bonds, Cd can
demolish countless enzymes/proteins via oxidative stress. Hand-in-hand with Cd, Hg and Pb are
also able to cause renal proximal tubular acidosis and osteomalacia, additionally Hg and Pb have
been reported to act as competitive inhibitors of ZIP8-mediated Cd and Zn uptake (9). Platinum
and uranium are the only other metals known to cause this human condition.
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Table 1.3 Comparison between mouse and human Slc39A8, (ZIP8), and Slc39A14, (ZIP14),
genes (61)

Mouse Slc39a8 gene

Mouse Slc39a14 gene

Chromosomal
location

Chr 3; nt 135488243(+)

Chr 14; nt 70751231(-)

Transcript distance
spanned#a

64,860 bp

92,502 bp

Size of mRNA

3.1–3.3 kb

2.0 kb

Molecular weight
of protein

50,082 Da

53,754 versus 53,962 Da

Number of amino
acids in protein

462

489

Human SLC39A8 gene

Human SLC39A14 gene

Chromosomal
location

4q22–q24

8p21.2

Transcript distance
spanned

88,148 bp

57,942 bp

Size of mRNA

3.3–3.5 kb

4.6 kb

Molecular weight
of protein

49,631 Da

54,056 versus 54,212 Da

Number of amino
acids in protein

461

492
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Table 1.4 Properties of the mouse ZIP8 and ZIP14 proteins (61)

Properties

ZIP8

ZIP14A

ZIP14B

Tissues in which gene is
expressed most highly
(assessed by Northern
and qRT-PCR)

Lung = testis >

Liver > duodenum>

Liver = duodenum >

> kidney >> liver >

> kidney > testis>

>brain = testis >

> brain > duodenum

>brain = lung

>kidney = lung

Zn, Mn, Cd

Zn, Mn, Cd

Zn, Mn, Cd

Mn 2.2 μM;

Mn 18 μM;

Mn 4.4 μM;

Cd 0.62 μM

Cd 1.1 μM

Cd 0.14 μM

Mn > Hg >> Pb = Cu
= Zn = Cs

Zn >> Mn > Cu

Zn >> Mn > Cu

Zn, Cd

Zn, Cd

Zn, Cd

Zn 0.26 μM;

Zn 0.38 μM;

Cd 0.30 μM

Cd 0.48 μM

Cd 0.46 μM

Zn > Cu = Pb = Hg

Hg = Pb > Zn > Cu >
Fe > Mn

Cations transported by
mammalian cells in
culture (always with
HCO3-)

Km values for M2+
uptake in mammalian
cell culture

Cation inhibitors of Cd
uptake in mammalian
cell culture

Cations transported by
Xenopus oocytes
Km values for Cd
uptake in Xenopus
oocytes
Cation inhibitors of Cd
uptake in Xenopus
oocytes

Hg = Pb > Zn > Fe >
Cu > Mn

39

1.7 What is known about ZupT?
ZupT is a cytoplasmic membrane protein, which was the first characterized bacterial
member of the ZIP family of metal ion transporters, previously only believed to be present in
eukaryotes (57). Its gene was first discovered in Escherichia coli, and it formerly went by ygiE
(93). Before 2002, it was believed that there were only three Zn transport systems available in
E.coli: the efflux of Zn was mediated by the P-type ATPase ZntA and the cation diffusion
facilitator ZitB, while during Zn deficiency Zn was taken up by the high-affinity ABC
transporter ZnuABC (54, 127, 132). Grass et. al showed that ZupT was an additional Zn
transporter system, which facilitated Zn’s uptake in E.coli (57). Furthermore, as seen earlier with
other ZIP family proteins, ZupT also plays an important role in a number of different diseases.
For instance, during urinary tract infection (UTI) in mice, Znu and ZupT were essential for
growth in Zn-limited conditions (130). It was also reported that Znu was the main Zn transporter,
and that the loss of Znu and ZupT had a collective effect on fitness during UTI, which in turn
could have resulted from reduced resistance to oxidative stress and motility (130).
Multiple reports have showed ZupT to be a transporter of broad substrate specificity (55,
119). Besides Zn, ZupT was reported to mediate uptake of 55Fe2+ (55). It was reported that an E.
coli strain, whose known Fe uptake systems were demolished, was able to grow in the presence
of chelators only if zupT was expressed (55). Also, in the same strain, heterologous expression of
Arabidopsis thaliana ZIP1 alleviated the Fe deficiency (55). Additionally, ZupT’s expression
resulted in E. coli cells’ hypersensitivity to Co2+ and Mn2+ (55). Along with already mentioned
uptake of Zn, Fe, and Co, phenotypic and transport analysis reported ZupT is also involved in
transport of Mn, but also Cd2+ (119). According to competition experiments ZupT showed a
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slight preference for Zn, which was supported by kinetic parameters for Zn, when compared to
Co and Mn (119). ZupT was also observed to transport Cu2+ (119). Although, copper-uptake into
E. coli cells, and the role of ZupT in it, is physiologically not relevant because there is no
cytoplasmic protein known that requires a copper co-factor in E. coli. Interestingly, ZupT does
not seem to be metal regulated: expression of a Φ(zupT-lacZ) operon fusion showed that zupT is
expressed constitutively at a low level (55).
In silico analysis suggested that most ZIP transporters including ZupT have a topology
comprising of eight TMH along with an expanded loop domain between TMH III and IV(129,
114). Amino acid sequence analysis of different ZIPs revealed several conserved residues
between eukaryotic and prokaryotic ZIP proteins, which are for the most part located in TMH VI
and V (119). Site-directed mutagenesis has been done on a number of amino acid residues within
the ZupT sequence with a goal to identify the residues contributing to its substrate specificities. It
has been reported that ZupT with a H89A mutation has lost Co and Fe transport activity, while
the S117V mutant could no longer transport Mn (119). E152D mutant, on the other hand,
displayed general metal uptake impairment but completely lost its ability to mediate the transport
of Zn and Mn (119). After four amino acid residues in IRT1 (H197, S198, H224, E228) were
found to be vital for transport activity, similar residues were investigated in the shorter ZupT
peptide at similar positions but not in conserved order (S117, H119, H148, E152) (129, 119).
Here, only mutations H119 and H148 left the protein basically inactive (119). Furthermore,
mutations of S117, and E152 residues also displayed distinguishing phenotypes. For instance, the
S117V mutant lost its Mn-transport activity, along with a minor reduction in Co-uptake, while
cells with E152D or E152A were unable to take up Zn and Cd or Zn, respectively (119). In
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addition, mutation of E60 residue led to loss of Cd, and to some degree also Co, transport
without having any effects on other substrates (119). In growth experiments, ZupT E60D mutant
was similar to wild-type ZupT, but its uptake-activity was altered (119). Finally, even though the
negative charge of this glutamate was retained, since it was mutated to aspartate, its transport
abilities were impaired. Furthermore, this mutant’s ZupT protein was synthesized in low
quantity, as it was barely detectable by immuno-blotting (119).
One of the proposed mechanisms for metal uptake by ZupT included the proton motive
force because the protonophores FCCP and CCCP were reported to inhibit the metal transport
(119). Studies were conducted to address this issue. If metal transport by ZupT depended on
proton force, its mechanism would be similar to that of MntH, where maximum transport is
achieved at low pH (24). The opposite was observed for ZupT and other ZIP transporters. ZupT
was shown to work best at physiological pH (119). Its metal uptake was independent of K+-,
Na+- or Mg+-ions, thus showing that it did not participate in a substrate co-transport with these
cations (119). ZupT’s affinity for its substrates might increase with increasing pH, and therefore
its transport efficiency is reported to be higher at near neutral pH. Likewise, one can explain
ZupT’s increased transport of Zn at increasing pH levels. Finally, it could be due to the pH of the
outside environment, which could be responsible for the protonation-state of the amino acid
residues within ZupT, that ZupT’s optimal activity was observed at pH 7.2 (119). Also, at neutral
pH ZupT’s metal uptake into the cells was inhibited by ionophores (119). Interesting to note,
mammalian ZIP8’s Cd-transport was energy-dependent but, similarly to ZupT, independent of
K+-, Na+- or Cl--ions (60). ZupT also seems to be unlike its eukaryotic ZIP homologues due to its
lack of stimulation by bicarbonate (119). Alternative mechanism proposed that metal-uptake by
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ZupT might be driven just by the concentration gradient of labile transition metal cations found
across the plasma membrane (16). If one were to change the pH gradient across the membrane
by let’s say two orders of magnitude: it would most likely be insufficient since the concentration
gradient of Zn across the cytoplasmic membrane is at least 14 orders of magnitude (16).
There was a comparison conducted between ZupT and ZIP family members from
eukaryotes. Through the means of retroviral infection of fetal mouse fibroblast cultures with
ZIP8 cDNA, transport kinetics of ZIP8 for Cd2+ and Mn2+ were obtained with apparent K
values as 2.2 and 0.69 μM as well as V

max

m

values of 73.8 and 92.1 pmol × min-1 × mg protein-1,

respectively (60). These results were similar to the reported results from metal transport study
with ZupT and Mn2+: K

m

1.16 ± 0.29 μM Mn, with a V

max

850 ± 90 pmol × g d.w.-1 × min-1

(119). The reported apparent affinity of ZupT for Zn2+: 0.71 ± 0.14 μM Zn2+ in E. coli was in the
same order of magnitude to what was observed for ZIP8 and Zn2+: K
similar to what was measured for IRT1 expressed in yeast: K

m

m

= 0.26 μM Zn2+, and

= 2.8 μM Zn2+ (119, 60, 90).

Interesting to note, metal competition studies showed that ZIP8-mediated Cd2+ -transport was
inhibited by other metal cations especially by Mn2+, Hg2+ and Pb2+ but not by Fe2+ or Ni2+ (60).
An additional study reported that Cd2+ transport into Xenopus oocytes through ZIP8 was well
inhibited by Zn2+ but not by Mn2+ (107). ZupT transport of Zn2+, on the other hand, was not
inhibited but somewhat elevated by presence of Fe2+, even though Fe2+ is one of its substrates
(119). Similarly, in IRT1 Fe2+ but not Fe3+ also led to an increase in Zn2+ -uptake rate (90).
Likewise, Zn2+ transport by ZIP8 and ZIP14 was increased in the presence of the alternative
substrate Fe2+ (53). Therefore, transport by ZIP proteins ZIP8, ZIP14, IRT1 as well as ZupT
follows typical Michaelis–Menten kinetics (53). If this was not the case and an allosteric
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regulation by Fe2+ of ZupT-mediated Zn-transport was involved, in an inverse experiment, Fe2+
transport would be controlled by Zn. On the contrary, a 50-fold surplus of Zn over Fe2+ did not
diminish Fe2+-uptake by ZupT (119).
Without a purified ZupT protein its true biochemistry is difficult to characterize.
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CHAPTER 2
EXPERIMENTS, RESULTS & DISCUSSION

2.1 Goal
As described in Chapter 1, ZIP family of metal transporters is expressed amongst
different organisms in order to maintain their metal homeostasis and thus contribute greatly to
their growth and development. ZIPs have also been found to play key roles in bacterial
infections, as well as the onset and progression of chronic diseases in humans.
The goal of this study was to purify and characterize one of the bacterial ZIP transporters:
E.coli ZupT. Studies conducted in E.coli can provide a great number of characteristic data for
such transmembrane proteins like ZupT. In comparison with mammalian cells, E.coli’s lack of
complex organelles, and ease of genetic analysis, allows for direct analysis of the protein’s role
in metal transport. Furthermore, in vivo and in vitro studies can be conducted in this system.
As outlined in Chapter 1, various ZIP transporters have been reported to have different
metal binding specificities. After ZupT purification, its binding specificities will be evaluated
with fluorescence and UV-Visible spectroscopies. Also, to determine the binding
stoichiometries, between ZupT and the tested metals, ICP-MS (inductively coupled mass
spectrometry) analysis will be conducted.

2.2 Materials
pBAD/mycHis-C plasmid and the E.coli strain LMG194 were purchased from Invitrogen.
The pBAD/mycHis-P plasmid was constructed by our collaborator’s lab.
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2.3 Methods
2.3.1 Construction of ZupT/pBAD/mycHis-P with carboxyl-terminal Precision Protease site
ZupT was subcloned from pBAD/mycHis-C into pBAD/mycHis-P with an addition of a
protease site (Figure 2.1). The amplified PCR products were cloned into pBAD/mycHis-P with
the help of BamHI and EcoRI sites. The creation of the construct was verified with sequencing
by GENEWIZ. The final construct was later transformed into TG1 cells and later into LMG194
cells.

Figure 2.1
ZupT subcloned from pBAD/mycHis-C into pBAD/mycHis-P with an addition of a Precision
Protease site
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2.3.2 Creation of ZupT/pBAD/mycHis-C mutants
CLUSTALW2 Multiple Sequence Alignment (European Bioinformatics Institute) was
used to analyze the ZupT sequence. The sequence analysis revealed two homologicallyconserved regions (Figure 2.2), which differed from the previously described conservation found
in other ZIP family proteins. When compared to the topological model of SLC39 proteins
(Figure 1.5), where there is a H-rich region between transmembrane (TM) III and IV, followed
by conserved H, S, and E residues, ZupT sequence alignment revealed two repetitive, almost
perfectly-conserved, regions (Figure 2.2). With a general sequence of HN-X-PEG, the first
region had a 100% conservancy in H, E, and G residues. Second region only had G at the 100%
conservancy. In order to evaluate a possible metal-binding role of these two conserved regions,
several ZupT mutants were created.
After designing of primers, QuickChange Site-Directed mutagenesis Kit (Stratagene) was
utilized in order to create four different mutants. Mutants had a restriction enzyme site inserted
into the sequence, highlighted, in order to speed up and confirm the mutation creation (Table
2.1). Successful mutants creation was confirmed with sequencing by GENEWIZ.
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Table 2.1 ZupT Site-Directed Mutagenesis Primers
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2.3.3 Optimization of ZupT expression
Protocol for optimization of ZupT was modified from the reported protocol in reference
133. First, a log phase growth curve was created for ZupT/pBAD/mycHis-C, in LMG194. After
a fresh transformation of ZupT/pBAD/mycHis-C into LMG-194 cells 5 colonies were selected
and grown in 5-ml LB cultures with Amp, in a 50-ml tube with lids hole-punched 3 times. The
OD600 of the negative control culture was checked every 30 min in order to construct a log phase
growth curve. The remaining colonies # 1-6, plus a negative control colony, were grown to
OD600 0.8 at which point 125 ul of the cultures were plated on a LB/ Amp (100 mg/ml) plates
and the remainder of the cultures, besides the negative control, were induced with 0.02%
Arabinose. The cultures were grown additional 1.5 h at 37°C, at which point 500-ul samples
were taken, followed by 18 h growth at 25°C. After overnight growth, 500-ul samples were
taken again from all of the cultures and pelleted. The supernatant was discarded and the pellets
were treated with 20 ul of SDS loading buffer. The samples were digested at 95°C for 20 min.
Samples from 1.5-h of induction and those with additional 18 h of induction at room temperature
were compared on a 12% SDS gel. An overall increased protein expression was observed for all
the colonies thus longer culturing/induction time was implemented.
The original ZupT expressions of the 7 freshly-transformed colonies were compared on a
western blot (Figure 2.5). As a result, colony # 5 was chosen and underwent a 2nd selection as
described earlier, again with a negative control and # 1-6 colonies compared. Finally, the results
of both selections, colonies # 5 and # 3, were compared on a 12% SDS gel (Figure 2.6). As seen
in Figure 2.6, a higher ZupT-expressing colony was isolated.
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2.3.4 Purification of ZupT
After the newly made construct ZupT/pBAD/mycHis-P was retransformed into LMG194,
as described in the Appendix of this manuscript, an overnight culture was grown with 1 of the
colonies resulting from the transformation, to OD600 = 0.10, followed by growth of a 125-ml
overnight culture with 1 ml of the previously grown culture, to OD600 = 1.71. This culture was
used to grow 2-L cultures in a shaker at 37C for 3.5 h until OD600 = 0.80. These were induced
with 0.4 g of Arabinose, after which the cultures were grown an additional 1.5 h at 37C. Lastly,
the cultures were incubated for 18 h more at 25C. Final average OD600 = 1.03 (n = 3). The cells
were harvested at 7,000 rpm and the average of the obtained pellet was 1.33 g/L (n = 3). The
combined pellets were resuspended at ~ 7.90 ml/g of cells. The buffer A used for the
resuspension included 25 mM Tris, pH 7.0, and 100 mM sucrose. After addition of DNase I the
cells were stirred at 4C for 30 min, after which PMSF was added to a final concentration of 1
mM.
The cells were then lysed twice with a French press at 20,000 p.s.i. and collected
immediately into a tube that was kept on ice. 2 mM MgCl2 was added immediately after the
French press. The cell suspension was stirred again at 4C for 30 min. Low speed centrifugation
was performed at 8,500 rpm for 40 min. In order to separate the membranes from the soluble
fraction of cells, the supernatant from the low speed centrifugation underwent a high speed
centrifugation at 45,000 rpm for 1 h. The resulting pellets from high speed centrifugation were
resuspended to OD280 = 20 with the following buffer B: 25 mM Tris, pH 7.0, 100 mM sucrose,
500 mM NaCl, and 1 mM 2-BME. Then at 4C Triton X-100 was added very slowly, while
stirred, to a final concentration of 2%. The suspension was stirred at 4C for 1 h. The above
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underwent ultra-centrifugation at 45,000 rpm for 80 min in order to remove the insoluble
fraction. A charged, 5-ml bed, Ni2+ - pro-bond column was prepared by successive washes of 50
ml dH2O and 15 ml of buffer C (25 mM Tris, pH 7.0, 100 mM sucrose, 500 mM NaCl, 1 mM
PMSF, 1 mM 2-BME, and 2 mM DDM). The supernatant, resulting from ultra-centrifugation,
was loaded onto the column and washed with 50 ml of buffer C, 100 ml of buffer C and 50 mM
Imidazole, 50 ml of buffer C and 100 mM Imidazole, and the protein was finally eluted with 20
ml of buffer C and 300 mM Imidazole. 1 ml fractions were collected during the elution step and
checked for the presence of protein with a bichinchonic acid assay (Sigma), while using bovine
serum albumin as standard. The protein-containing fractions were concentrated with an Ultracel10 kDa centricon (Millipore), at 3,500 rpm until desired volume was achieved. The Imidazole
was removed with a use of a 40-ml Sephadex G-25 column. The protein fractions were
concentrated again with an Ultracel-10 kDa centricon. Finally, the aliquots of the protein were
stored at -80°C with a final 10% glycerol concentration, which was used as a cryoprotectant.
2.3.5 Characterization of ZupT using Fluorescence Spectroscopy
The samples for the fluorescence spectroscopy analysis were prepared in HPLC H2O with
10 mM Tris, pH 7.0, and 2 mM DDM. 10 uM protein concentration of ZupT was used for all
experiments. Metal solutions utilized for the experiments were made in mqH2O at 1 mM and 10
mM final concentrations. After each addition of a metal solution, the samples were thoroughly
mixed by inversion of the cuvet 20 times, with parafilm used as a stopper. The samples were
excited at 290 nm and the emission scans were taken from 300-500 nm.
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2.3.6 Characterization of ZupT with UV-Visible spectroscopy
Here, same protein, buffer and metal concentrations were used as for fluorescence studies
described above. Scans were taken from 190 nm-900 nm in order to find any changes due to the
binding of the metal tested. Later scans were narrowed down to a 190 nm-500 nm range for Fe.
2.3.7 Obtaining metal binding stoichiometry with ICP-MS
The metal concentrations were measured with the use of a PE Sciex Elan 9000 ICP-MS with
a cross-flow nebulizer and Scott type spray chamber. The RF power used during the analysis was
1000 W, and the argon flow was optimized at 0.92 L/min. All the metal standards used were
obtained from VWR.
10 uM protein samples were prepared in the buffer (HPLC H2O with 10 mM Tris, pH 7.0,
and 2 mM DDM) along with 150 uM final metal concentration. All metals were added very
slowly with a 10 ul syringe, after which samples were thoroughly mixed. Samples were then
incubated for 20 min and then loaded onto a 1.5-ml Sephadex G-25 column. The column was
washed with 15 ml mqH2O and 4.5 ml of the sample buffer (HPLC H2O with 10 mM Tris, pH
7.0, and 2 mM DDM). The samples were passed through the column and eluted with the above
described buffer. BCA assay was utilized to identify the protein-containing fractions and those
were concentrated to a minimum volume at 3,500 rpm using an Ultracel-10 kDa centricon. The
washing of the column and eluting the sample were repeated once more for a total of 2 times in
order to wash out the excess/unbound metal. BSA assay was performed to measure the exact
protein concentration of the samples: duplicate readings were taken at 562 nm.
The samples were then prepared for ICP-MS analysis, using final concentrations of 2% Nitric
acid in all samples. At last, the samples were diluted with HPLC water to 2 ml final volume.
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Final binding stoichiometry was obtained by first calculating all the metal and protein
concentrations to uM units and then dividing the metal concentrations by the protein
concentrations.

2.4 Results
2.4.1 ZupT sequence analysis
As a result of CLUSTALW2 Multiple Sequence Alignment (European Bioinformatics
Institute) the following 2 conserved regions, inside TM IV and V, were found within E.coli ZupT
sequence and its homologues throughout the different kingdoms (Figure 2.2).

Chlorobium
Methanosaeta
Oryza
Aeropyrum
Schizosac.
Zip1
E.coli

--------------------------------LNRMGLFTAAAIAIHNFPEGMAVFFSA
----------------------------HCSTLYRSSIMSAIGIAIHNLPEGMAVALVS
--------------------------KKHRRQVLFSGIITAVGISLHNFPEGMAVFLGS
------------------------PPSFRRKVKAAWLVATAIII--HNLPEGMSIGAAA
SMATCACECHHPDQQAPSILSGSSCGSDHEKSMFTVGLQTAIAISLHKLPEGFIIFMTS
------------------VPQ-A-SG-APATPSALRACVLVFSLALHSVFEGLAVGLQR
----------------------------LPKSIKRTAILLTLGISLHNFPEGIATFVTA

134
127
145
148
228
191
151

TM IV
Chlorobium
Methanosaeta
Oryza
Aeropyrum
Schizosac.
Zip1
E.coli

LSNQNLGIVIATTIALHNIPEGMAIAVPIYFATKSRKKAFTY-SFLSGLAEPLGAIVG
LSDIHLGVPIALAIAIHNIPEGIACSVPFYCATN-KRGRSCLISFAAGMTEPLGAVLA
MKGLRVGLNLAIAIALHNIPEGVAVALPLYFATNSKWQAFKV-ATLSGFAEPLGVIIV
SYAISEGLAVALAIGTQDFPEGLAVSLPVFAASGSLYLALLVAMLSGFS-EVVAATIV
SSDAGMLVFLAMSV--HNLFEGFTIAYPLYLAWHSRFRSFLVGSALTTTSMPLGALLA
DRARAMELCLALL--LHK---GILAVS-LSL-RLLQSHLRAQVVAGCGILFSCMTPLG
SSNLELGFGIALAVALHNIPEGLAVAGPVYAATGSKRTAILW-AGISGLAEILGGVLA
TM V

Figure 2.2
Two homologically-conserved regions in ZupT
*Only the conserved regions are presented.

TM VI

193
185
203
206
285
248
172
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2.4.2 Optimization of ZupT expression
After obtaining a log phase growth curve for ZupT in pBAD/mycHis-C, in LMG194, a
double-selection protocol was utilized in order to obtain a high-expressing ZupT colony in
LMG194. The original ZupT expressions of 7 freshly-transformed colonies of ZupT in
pBAD/mycHis-C, in LMG194, with 1 used as a negative control (uninduced), were compared on
a western blot, after which colony # 5* was chosen as the 1st selection (Figure 2.3).

1

2

3

4

5

Figure 2.3
Western blot comparison of ZupT expression before 1st selection
Legend:
1. Negative Control (uninduced)
2. Colony 1
3. Colony 2
4. Colony 3
5. Colony 4
6. Colony 5*
7. Colony 6

6*

7
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Colony #5 resulting from the 1st selection was compared to colony #3 resulting from the
2nd selection (Figure 2.4).

1

2

3
Legend:
1. 1st selection colony 5 uninduced
2. 1st selection colony 5 induced
3. 2nd selection colony 3 induced

Figure 2.4
Resulting colonies from 1st selection and 2nd selections were compared on a 12% SDS gel
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2.4.3 ZupT purification
The fractions collected during ZupT/pBAD/mycHis-P purification were analyzed along
with the purified ZupT on a 12% SDS gel Figure 2.5 (A) and a 15% SDS gel Figure 2.5 (B).
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7

1

2

3

4

5

6

7

45 kDa

31 kDa

A

B

Figure 2.5
SDS gels with fractions obtained during ZupT/pBAD/mycHis-P purification: (A) a 12% SDS gel
and (B) a 15% SDS gel.
Legend:
1. HSP1 - 1st high speed pellet
2. HSS2 - 2nd high speed supernatant
3. HSP2 - 2nd high speed pellet
4. 100mM-Imidazole buffer
5. 300mM-Imidazole buffer
6. Purified ZupT concentrated
7. Marker
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2.4.4 ZupT characterization
Fluorescence characterization of ZupT/pBAD/mycHis-P was conducted in order to
evaluate its metal binding specificities. 10 uM ZupT/pBAD/mycHis-P was used throughout the
characterization experiments along with a neutral pH buffer, which was deemed optimum for
ZupT’s transport activity (119). All the samples were excited at 290 nm.
2.4.4.1 Titration of fluorescence emission of ZupT with Cd
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Figure 2.6
300–500 nm emission spectrum of ZupT/pBAD/mycHis-P with Cd
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Figure 2.7
300-400 nm emission spectrum of ZupT/pBAD/mycHis-P with Cd
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Figure 2.8
Fluorescence study 330.9 nm peak analysis: Fluorescence vs. [Cd] (uM)
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2.4.4.2 Titration of fluorescence emission of ZupT with Fe
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Figure 2.9
300-500 nm emission spectrum of ZupT/pBAD/mycHis-P with Fe
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Figure 2.10A
300-400 nm emission spectrum of ZupT/pBAD/mycHis-P with ↓ [Fe]
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Figure 2.10B
300-400 nm emission spectrum of ZupT/pBAD/mycHis-P with ↑ [Fe]
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Figure 2.11
Fluorescence study 330.9 nm peak analysis: Fluorescence vs. [Fe] (uM)
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2.4.4.3 UV-Visible spectroscopy study with Fe

Wavelength (nm)

Figure 2.12
10 uM ZupT/pBAD/mycHis-P UV-Vis absorbance peak
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so does the peak.
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Figure 2.13
Fe UV-Vis peak minus the ZupT/pBAD/mycHis-P absorbance peak
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Figure 2.14
UV-Vis 329.6 nm peak analysis: Absorbance vs. [Fe] (uM)
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2.4.4.4 Titration of fluorescence emission of ZupT with Pb
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Figure 2.15
300-500 nm emission spectrum of ZupT/pBAD/mycHis-P with Pb
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300-400 nm emission spectrum of ZupT/pBAD/mycHis-P with Pb
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Figure 2.17
Fluorescence study 330.9 nm peak analysis: Fluorescence vs. [Pb] (uM)
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2.4.4.5 Titration of fluorescence emission of ZupT with Zn
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300-500 nm emission spectrum of ZupT/pBAD/mycHis-P with Zn
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2.4.4.6 ICP-MS metal binding stoichiometries

Table 2.2 ICP-MS ZupT/pBAD/mycHis-P metal binding stoichiometries

Metal

ZupT/pBAD/mycHis-P binding
stoichiometry

Cd2+

32.03 ± 0.03

Pb2+

0.07 ± 0.0

Zn2+

6.09 ± 0.0
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2.5 Discussion
As a result of this study a successful protocol has been established for purification of
ZupT. The detailed purification procedure for ZupT is outlined in Appendix (p. 79) of this
manuscript. It was found that the lysing of the cells with a French press was more efficient if the
resuspended cells were treated with DNase I before the lysing. In addition, while the membrane
was solublized with Triton X-100, it was crucial to use DDM and not Triton X-100 in all of the
washing/eluting buffers during the ZupT purification. For protein characterization purposes
DDM was also a better suited eluting detergent than Triton X-100 because Triton X-100
produces absorbance at 280 nm and below.
Moreover, optimization of ZupT expression was successfully achieved through a doubleselection method (Figures 2.3 & 2.4). ZupT, which has been described by others and observed
personally as a low-expressing protein, is now expressed enough to be seen from a cell fraction
on an SDS gel (Figure 2.4) (55, 119). After utilizing this method, the optimum growth and
induction conditions for ZupT were also obtained: with initial growth at 37°C, for 3.5 h, with
induction at OD600 of 0.8, followed by additional 1.5 h of growth at 37°C, and finally 18 more
hours of growth at 25°C.
All the characterization techniques of ZupT were conducted using neutral pH buffers,
which were previously mentioned as to be optimum for its binding efficiency (119). The above
results of the fluorescence studies showed that the technique itself is a reliable technique for
studying metal binding for a transmembrane protein, such as ZupT. The original
ZupT/pBAD/mycHis-P fluorescence peak resulted from the presence of 2 Tryptophan residues
residing at 173 and 189 amino acid sequence. All four metals showed a notable blue-shifting of
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the original peak. The peak shifted from ~330.9 nm to forming a second peak at ~313.9 nm, and
then depending on the metal it was binding, increasing metal concentration resulted in the overall
peak shifting back to the original one, as seen with Cd, or eventually showed a steady increase at
the newly made peak, as apparent with Pb. Blue-shifting is characteristic of the metal-binding
environment becoming more non-polar.
Overall ZupT/pBAD/mycHis-P’s fluorescence gradually decreased with the increased Cd
concentration (Figure 2.8). There was an increase in the fluorescence observed at 0.05 uM Cd:
1.0 uM ZupT/pBAD/mycHis-P at ~ 330.9 nm, followed by blue-shifting of the peak to forming a
second peak at ~315.0 nm (Figure 2.7). At 1.0 uM Cd: 1.0 uM ZupT/pBAD/mycHis-P the peak
at ~315.0 nm disappeared and only a peak at 330.9 nm was prominent. The 330.9 nm peak
decreased drastically at 2.0 uM Cd: 1.0 uM ZupT/pBAD/mycHis-P and blue-shifted again to
~315.0 nm. At 6.0 uM Cd: 1.0 uM ZupT/pBAD/mycHis-P both peaks seemed to have reached
saturation. Last jump in fluorescence, at 330.9 nm, was observed at 7.0 uM Cd: 1.0 uM
ZupT/pBAD/mycHis-P after which the fluorescence kept decreasing staying at the original peak
range (Figures 2.7, 2.8). Analysis of the 330.9 nm peak suggested two possible binding sites: one
with a high affinity and another one with a lower affinity (Figure 2.8). ICP-MS results for Cd
binding to ZupT showed a 2-fold higher concentration of Pb in the sample along with Cd, which
was deemed unacceptable. Overall, the Cd stoichiometry for the sample was 32.03 Cd to 1
ZupT/pBAD/mycHis-P.
The data obtained from the fluorescence study with Fe revealed possible binding of Fe to
ZupT. The original 330.9 nm peak blue-shifted at 0.1 uM Fe: 1.0 uM ZupT/pBAD/mycHis-P
ratio to ~313.9 nm (Figure 2.10A). At 0.15 uM Fe: 1.0uM ZupT/pBAD/mycHis-P ratio the peak
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shifts back to the original peak at ~330.9 nm and an increase in fluorescence is observed (Figure
2.10A). With increased fluorescence intensity, the peak blue-shifted and increased once more at
0.175 uM Fe: 1.0 uM ZupT/pBAD/mycHis-P ratio. There was a decrease of the fluorescence
observed, at 313.9 nm peak, when 0.25 uM Fe: 1.0 uM ZupT/pBAD/mycHis-P ratio was
reached. Furthermore, there was another shift back to 330.9 nm peak at 0.275 uM Fe: 1.0 uM
ZupT/pBAD/mycHis-P ratio. An additional blue-shift was observed at 0.3 uM Fe: 1.0 uM
ZupT/pBAD/mycHis-P ratio. This peak kept increasing until 0.7 uM Fe: 1.0 uM
ZupT/pBAD/mycHis-P ratio is reached, at which point there was a drastic decrease at 0.75 uM
Fe: 1.0 uM ZupT/pBAD/mycHis-P ratio, at which point the peak drastically dropped to the
original saturation level (Figure 2.10A). After 0.75 uM Fe: 1.0 uM ZupT/pBAD/mycHis-P ratio,
the fluorescence of the 313.9 nm kept increasing until 0.85 uM Fe: 1.0 uM ZupT/pBAD/mycHisP ratio after which it began decreasing with one last jump in fluorescence at 1.0 uM Fe: 1.0 uM
ZupT/pBAD/mycHis-P ratio ratio (Figure 2.10A, 2.10B). UV-Visible spectroscopic studies have
also shown possible binding of Fe by the presence of an increasing broad range peak from
~230.0 nm – 390.0 nm (Figure 2.13). Further analysis of absorbance vs. [Fe] (uM) suggested two
biding sites with first saturation at 0.25 uM Fe: 1.0 uM ZupT/pBAD/mycHis-P ratio, and a
second saturation at 1.0 uM Fe: 1.0 uM ZupT/pBAD/mycHis-P ratio (Figure 2.14). ICP-MS
sample with Fe was prepared and is awaiting analysis to shine more light on stoichiometry
between Fe and ZupT.
There is a striking resemblance between Cd’s and Fe’s final fluorescence saturations: 7.0
uM Cd: 1.0 uM ZupT/pBAD/mycHis-P ratio for Cd and 0.7 uM Fe: 1.0 uM
ZupT/pBAD/mycHis-P ratio for Fe. According to this fluorescence data there is a possible 10-
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fold difference in affinity between these two metals. It is not surprising that there is a similarity
in these fluorescence profiles, because according to Frank Thévenod, Cd is believed to be
utilizing Fe’s uptake pathways for its transport in mammalian cells (48). The same can be
expected in E.coli cells.
On the other hand, the data obtained from the fluorescence study with Pb showed what
could be described as an unspecific binding with an overall increase in fluorescence (Figure
2.17). The original peak at ~330.9 nm saturated at 1.0 uM Pb: 1.0 uM ZupT/pBAD/mycHis-P
(Figure 2.16). Then at 2.0 uM Pb: 1.0 uM ZupT/pBAD/mycHis-P the peak blue-shifted from
~330.9 nm to forming a second peak at ~313.9 nm after which it shifted back again to the
original peak at 4.0 uM Pb: 1.0 uM ZupT/pBAD/mycHis-P. Finally, the peak blue-shifts one last
time at 5.0 uM Pb: 1.0 uM ZupT/pBAD/mycHis-P after which there is a steady increase of
fluorescence at ~313.9 nm peak (Figures 2.15, 2.16). ICP-MS data showed a binding
stoichiometry of 0.07 Pb 207 to 1 ZupT/pBAD/mycHis-P. This shows that Pb is not bound to
ZupT with high affinity; the changes in fluorescence reflect non-specific weak binding.
The data obtained from the fluorescence binding study with Zn showed a possible
saturation of 2 metal-binding sites (Figure 2.20). The original peak at ~330.9 nm blue-shifted to
~313.9 nm at 0.2 uM Zn: 1.0 uM ZupT/pBAD/mycHis-P (Figure 2.19). The newly formed peak,
along with the original peak, continued to increase up to 5.0 uM Zn: 1.0 uM
ZupT/pBAD/mycHis-P ratio. Afterwards, the peak jumped higher and remained there until 10.0
uM Zn: 1.0 uM ZupT/pBAD/mycHis-P ratio is reached (Figure 2.19). Then another jump in
fluorescence was observed at 11.0 uM Zn: 1.0 uM ZupT/pBAD/mycHis-P ratio, after which
there is a significant decrease in fluorescence which places the peak below the previous level of
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saturation. Another increase in fluorescence is observed at 13.0 uM Zn: 1.0 uM
ZupT/pBAD/mycHis-P ratio, after which both peaks at 313.9 nm and 330.9 nm decrease steadily
(Figure 2.19). ICP-MS data showed a binding stoichiometry of 6.09 Zn 65 to 1
ZupT/pBAD/mycHis-P. Few of these could be coordinating at the two conserved Histidines
within ZupT itself, but also there’s a possibility of the His tag, found at the end of the sequence,
also binding the Zn atoms. However, metal binding to the His tag may or may not affect Trp
fluorescence.
2.6 Future Direction
The importance of the ZIP family of metal transporters throughout the kingdoms is
indisputable. Future investigation is needed in order to elucidate more structural data on one of
its more easy to characterize members: ZupT. Fluorescence studies are useful in investigating
different metals that ZupT might, and might not bind, as well as their possible affinities. UVVisible spectroscopy can also be useful in confirming binding of colored metals by ZupT.
Although, the number of binding sites, within ZupT, should only be investigated with
fluorescence studies while using very tightly-regulated metal titrations. ICP-MS studies have
shown to provide most reliable data and should be done for all investigated metals following the
procedure utilized during this study. Similar analysis should be performed for all the mutants
constructed during this study to further investigate the importance of the proposed metal binding
sites within ZupT.
Although these studies were conducted with a His-tagged ZupT, and will be repeated in
the future with non-tagged ZupT, they indicate that both fluorescence and UV-Visible
absorbance methods can be used to study metal binding to ZupT. Overall, different metals
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caused different changes in fluorescence, indicating that these changes were not solely due to the
His tag. Additionally, repeating these studies with the non-His-tagged mutant proteins will help
to determine whether these residues contribute to metal binding.

79

APPENDIX A: ZupT purification procedure
1. The new construct ZupT/pBAD/mycHis-P was retransformed into LMG194 strain as follows:











50 ul aliquot of WT-LMG194 competent cells were thawed on ice for 30 min
The cells were then transferred to a pre-chilled 15-ml Corning tube
Added 1 nanogram, 2 ul, of the plasmid
Swirled the mixture and incubated on ice for 30 min
Heat-shocked the cells at 42C for 1 min
Incubated again on ice for 2 min
Added 500 ul of preheated to 42C LB media
Incubated the tube, in the shaker, at 37C for 1 h
Plated the cells on 2 Amp/LB plates
Incubated overnight at 37C

2. A 5 ml LB/ 5 ul Amp culture was grown with 1 of the colonies, resulting from the
transformation, up to OD600 = 0.10.
3. An overnight culture of 125 ml LB/ 125 ul Amp was grown with 1 ml of the culture from
number 2.
4. For each 2-L of culture the following was added:




2 L of autoclaved LB media
0.2 g Amp
25 ml of the overnight culture from 3 above (OD600 = 1.71).

5. Incubated in a shaker at 37C for 3.5 h until OD600 = 0.80.
6. Induced each 2-L culture with 0.4 g of Arabinose.
7. The cultures were grown for an additional 1.5 h at 37C.
8. Lastly, the cultures incubated for 18 h at 25C.
9. Final average OD600 = 1.03 (n = 3).
10. Cells were harvested at 7,000 rpm.
11. Average pellet obtained per 2 L of culture was 2.66 g (n = 3).
12. The combined pellets were resuspended, approximately 7.90 ml of the buffer per 1 g of cells,
with the following Buffer A (VT = 150 ml):
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7.5 ml 0.5 M Tris (pH = 7)
15 ml 0.1 M Sucrose
127.5 ml dH2O

13. After addition of DNase I the cells were stirred at 4C for 30 min.
14. PMSF was added to a final concentration of 1 mM.
15. The cells were French pressed 2 times and collected immediately into a tube that was kept on
ice.
16. 2 mM MgCl2 was added immediately after the French press along with PMSF.
17. The cell suspension was stirred again at 4C for 30 min.
18. Low speed centrifugation at 8,500 rpm for 40 min.
19. Supernatant from low speed centrifugation underwent a high speed centrifugation at 45,000
rpm for 1 h.
20. The resulting pellets from high speed centrifugation were resuspended to OD280 = 20 with the
following Buffer B (VT = 300 ml):






204.79 ml dH2O
50 ml 3 M NaCl
30 ml 1 M Sucrose
15 ml 0.5 M Tris (pH = 7)
21 ul 2-BME

21. Added 2% Triton X-100: very slowly, at 4C, while stirred.
22. Stirred at 4C for 1 h.
23. Ultra-centrifuged the above at 45,000 rpm for 80 min.
24. Prepared Buffer C (VT = 400.0 ml):








272.6 ml dH2O
66.6 ml 3 M NaCl
40.0 ml 1 M Sucrose
20.0 ml 0.5 M Tris (pH = 7)
0.800 ml 1 M DDM
0.021 ml 2-BME
0.068 g PMSF

81

25. Preparation of Ni2+-pro-bond column:




Added 10 ml of the Ni2+-pro-bond solution to the column to make a 5-ml bed
Passed 50 ml of dH2O
Passed 15 ml of Buffer C

26. Loaded the supernatant, resulting from ultra-centrifugation in 23.
27. Washed the column:





50 ml of Buffer C
100 ml 50 mM Imidazole in Buffer C
50 ml 100 mM Imidazole in Buffer C
20 ml 300 mM Imidazole in Buffer C

28. Collected 1 ml fractions after 300 mM Imidazole in Buffer C.
29. Performed BCA assay (Sigma) to locate the protein-containing fractions.
30. Concentrated the fractions using an Ultracel-10 kDa centricon (Millipore), at 3,500 rpm until
desired volume was achieved.
31. Prepared Buffer D (VT = 150 ml):







119.7 ml dH2O
15 ml 1 M Sucrose
7.5 ml 1 M KCl
7.5 ml 0.5 M Tris (pH=7)
0.3 ml 1 M DDM
0.026 g PMSF

32. Preparation of G-25 column:



Passed 100 ml of dH2O
Passed 50 ml of Buffer D

33. With barely any buffer remaining on top of the column, loaded my concentrated fraction
from 30 above.
34. Allowed the fraction to go into the column and then added 15 ml of Buffer D again to the top
of the column in order to elute the protein.
35. Collected 1 ml fractions and located the protein utilizing the BCA assay.
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36. Pulled the protein-containing fractions and concentrated maximally at 3,500 rpm using an
Ultracel-10 kDa centricon (Millipore) again.
37. Made 75 ul aliquots of the protein with a final 10% glycerol concentration.
38. Stored the protein at -80C.
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APPENDIX B: ZupT characterization with Fluorescence Spectroscopy
1. Used the following Buffer E (VT = 10.0 ml):




8.995 ml HPLC H2O
1.0 ml 0.1 M Bis-Tris (pH = 7)
0.005 ml 1.0 M DDM

2. Final volume of the samples was 400.0 ul:



383.83 ul of the Buffer E
16.17 ul of ZupT, or 10.0 uM ([ZupT]= 247.36 uM)

3. All of the metal solutions were prepared in the following concentrations with mqH2O:



10.0 mM
1.0 mM

4. After each addition of a metal solution, the samples were thoroughly mixed by inversion of the
cuvet 20 times, with parafilm used as a stopper.
5. The samples were excited at 290 nm and the emission scans were taken from 300-500 nm.
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APPENDIX C: ZupT characterization with UV-Visible spectroscopy
ZupT binding to iron was measured with the use of a spectrophotometer. Same ZupT,
Buffer E, and metal concentrations were used as for fluorescence studies described above.
Scans were taken from 190 nm-900 nm in order to find a forming peak due to the binding
of the metal tested. Later scans were narrowed down to a 190 nm-500 nm range.
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APPENDIX D: Obtaining metal binding stoichiometry with ICP-MS
1. Sample preparation:




283.37 ul Buffer F (0.1 M Bis-Tris, pH = 7, with 2 mM DDM)
12.13 ul ZupT/pBAD/mycHis-P [247.36 uM]: 10 uM final concentration
4.5 ul metal [10 mM]: 150 uM final concentration
VT = 300.0 ul

2. All metals were added very slowly with a 10.0 ul syringe, after which samples were
thoroughly mixed. Samples were then incubated for 20 min and then loaded onto a G-25 column.
3. Preparation of G-25 column, with a bed of 1.5 ml:



15.0 ml of mqH2O
4.5 ml of Buffer F

4. The samples were passed through the column and eluted with the above described Buffer F.
5. BCA assay was utilized to identify the protein-containing fractions and those to a minimum
volume centrifuging at 3,500 rpm using an Ultracel-10 kDa centricon (Millipore).
6. # 3 above was repeated to wash out the excess metal and the samples were passed through the
column again.
7. BSA assay was performed to measure the exact protein concentration of the samples: took
duplicate readings at 562 nm.
8. Prepared the samples for ICP-MS analysis:




used maximum V of all the samples
added Nitric acid to a final concentration of 2%
diluted the samples with HPLC water to 2 ml final V

9. Calculated final binding stoichiometry for all metals: first calculated metal and protein
concentrations to uM units, and then divided metal concentrations by protein concentrations.
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In mammals zinc is the second most abundant essential trace metal. Since Zn2 is a small,
hydrophilic, and a highly charged ion, it cannot be transported across the plasma or intracellular
organelle membrane by passive diffusion. Different types of cells require a different constant
concentration of zinc at all times. Presence of excess free Zn ions can be toxic to the cell. All
cells must have tightly regulated homeostatic mechanisms in order to preserve healthy levels and
proper compartmentalization of zinc. This is accomplished through the actions of specialized
proteins that facilitate zinc uptake, efflux and compartmentalization. If the integrity of genes
responsible for maintenance of zinc homeostasis is compromised by mutations or
polymorphisms, this will likely result in complex genetic variations and even sensitivity to
dietary zinc in health and disease.
In E.coli, the uptake of zinc is mediated by two major types of transporters: ZnuACB,
which belongs to the cluster C9 family of (TroA-like) ATP-binding cassette (ABC) transporters,
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and ZupT, which is a member of the ZRT/IRT-related proteins (ZIP) family of transporters. ZIPs
are expressed amongst different organisms in order to maintain their metal homeostasis and thus
contribute greatly to their growth and development. ZIPs have also been found to play key roles
in bacterial infections, as well as the onset and progression of chronic diseases in humans.
In comparison with mammalian cells, E.coli’s lack of complex organelles, and ease of
genetic analysis, allows for direct analysis of the protein’s role in metal transport. In this study
E.coli’s ZupT was purified and characterized, and its expression was optimized with doubleselection method. The binding specificity for ZupT with Cd2+, Fe2+, Pb2+, and Zn2+ were
evaluated with fluorescence spectroscopy. Furthermore, UV-Visible spectroscopy was used to
further explore the binding of ZupT with Fe2+. The binding stoichiometry between ZupT and
Cd2+, Pb2+, and Zn2+ were determined utilizing ICP-MS (inductively coupled mass spectrometry)
analysis. Finally, based on the results of sequence analysis of ZupT, four mutants were
successfully created within transmembrane (TM) regions IV and V, which have been shown in
other ZIP family members to be crucial for metal binding.
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